BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 32612538)

  • 1. Changes in Myocardial Metabolism Preceding Sudden Cardiac Death.
    Snyder J; Zhai R; Lackey AI; Sato PY
    Front Physiol; 2020; 11():640. PubMed ID: 32612538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.
    Fukushima A; Milner K; Gupta A; Lopaschuk GD
    Curr Pharm Des; 2015; 21(25):3654-64. PubMed ID: 26166604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modifications in myocardial energy metabolism in diabetic patients]].
    Grynberg A
    Diabetes Metab; 2001 Nov; 27(5 Pt 2):S12-9. PubMed ID: 11910980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Modulators in Heart Disease: Past, Present, and Future.
    Lopaschuk GD
    Can J Cardiol; 2017 Jul; 33(7):838-849. PubMed ID: 28279520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial substrate metabolism in the normal and failing heart.
    Stanley WC; Recchia FA; Lopaschuk GD
    Physiol Rev; 2005 Jul; 85(3):1093-129. PubMed ID: 15987803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise-Induced Changes in Glucose Metabolism Promote Physiological Cardiac Growth.
    Gibb AA; Epstein PN; Uchida S; Zheng Y; McNally LA; Obal D; Katragadda K; Trainor P; Conklin DJ; Brittian KR; Tseng MT; Wang J; Jones SP; Bhatnagar A; Hill BG
    Circulation; 2017 Nov; 136(22):2144-2157. PubMed ID: 28860122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure.
    Dey S; DeMazumder D; Sidor A; Foster DB; O'Rourke B
    Circ Res; 2018 Jul; 123(3):356-371. PubMed ID: 29898892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid oxidation in the heart.
    Grynberg A; Demaison L
    J Cardiovasc Pharmacol; 1996; 28 Suppl 1():S11-7. PubMed ID: 8891866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac metabolism in myocardial ischemia.
    Rosano GM; Fini M; Caminiti G; Barbaro G
    Curr Pharm Des; 2008; 14(25):2551-62. PubMed ID: 18991672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Energy metabolism in cardiac remodeling and heart failure.
    Azevedo PS; Minicucci MF; Santos PP; Paiva SA; Zornoff LA
    Cardiol Rev; 2013; 21(3):135-40. PubMed ID: 22990373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pivotal role of membrane substrate transporters on the metabolic alterations in the pressure-overloaded heart.
    Geraets IME; Glatz JFC; Luiken JJFP; Nabben M
    Cardiovasc Res; 2019 May; 115(6):1000-1012. PubMed ID: 30938418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes.
    Fukushima A; Lopaschuk GD
    Biochim Biophys Acta; 2016 Oct; 1861(10):1525-34. PubMed ID: 26996746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.
    Scolletta S; Biagioli B
    Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 'Goldilocks zone' of fatty acid metabolism; to ensure that the relationship with cardiac function is just right.
    Kerr M; Dodd MS; Heather LC
    Clin Sci (Lond); 2017 Aug; 131(16):2079-2094. PubMed ID: 28739841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure.
    Fukushima A; Lopaschuk GD
    Biochim Biophys Acta; 2016 Dec; 1862(12):2211-2220. PubMed ID: 27479696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial metabolism in heart failure: Purinergic signalling and other metabolic concepts.
    Birkenfeld AL; Jordan J; Dworak M; Merkel T; Burnstock G
    Pharmacol Ther; 2019 Feb; 194():132-144. PubMed ID: 30149104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction.
    Fillmore N; Levasseur JL; Fukushima A; Wagg CS; Wang W; Dyck JRB; Lopaschuk GD
    Mol Med; 2018 Mar; 24(1):3. PubMed ID: 30134787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
    Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
    Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart.
    Bakrania B; Granger JP; Harmancey R
    J Vis Exp; 2016 Sep; (115):. PubMed ID: 27768055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between maternal and postnatal high fat diet leads to a greater risk of myocardial dysfunction in offspring via enhanced lipotoxicity, IRS-1 serine phosphorylation and mitochondrial defects.
    Turdi S; Ge W; Hu N; Bradley KM; Wang X; Ren J
    J Mol Cell Cardiol; 2013 Feb; 55():117-29. PubMed ID: 23266593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.